4. Jianxiang Zhang and Lingyu Wang."The Emerging World of TCR-T Cell Trials Against Cancer: A Systematic Review." Technology in Cancer Research and Treatment (2019).5. F. Manfredi, B. Cianciotti et al. "TR Redirected T Cells for Cancer Treatment: Achievements,Hurdles, and Goals." Frontie...
[2]Lu Y C,et al.Treatment of patients with metastatic cancer using a major histocompatibility complex class II–restricted T-cell receptor targeting the cancer germline antigen MAGE-A3[J]. Journal of Clinical Oncology,...
Wang, M."Treatment of metastatic nonsmall cell lung cancer with NYESO1 specific TCR engineeredT cells in a phase I clinical trial: A case report". Oncology Letters 16, no. 6 (2018): 6998-7007. https://doi.org/10...
想寻求TCR-T、CAR-T、TILs疗法或国内外其他抗癌新技术帮助的病友，可将治疗经历、近期病理报告及影像学检查结果等资料，提交至全球肿瘤医生网医学部，进行初步评估或申请国内外抗癌会诊，以寻求适合自己的个体化治疗方案。参考资料 [1]Liu C,et al.Validation and promise of a TCR mimic antibody for cancer immun...
2. The recent advancement of TCR-T cell therapies for cancer treatment (sciengine.com)3. Treatment of metastatic non-small cell lung cancer with NY-ESO-1 specific TCR engineered-T cells in a phase I clinical trial: A case report - PMC (nih.gov)4. Autologous T cell therapy for MAGE-A4...
T-cell receptor-engineered T cells for cancer treatment: current status and future directions. Protein Cell, 2018, PMID: 28108950. [4]Paul Shafer, Lauren M. Kelly and Valentina Hoyos.Explores novel approaches and diagnoses to treat immune disorders.Frontiers in Immunology.2022.Volume 13. [5]L ...
“应用TCR-T治疗HPV相关上皮癌的首次人体I/II期临床研究(NCT02858310)”,本次研究共入组12例中位年龄为50岁(范围32~70岁)的转移性HPV16阳性上皮癌患者,包括6例宫颈癌、4例肛门癌、1例口咽癌、1例阴道癌(其中三种宫颈癌肿瘤为腺癌,所有其他肿瘤均为鳞状细胞癌),并且之前均接受过铂类疗法,入组接受E6 TCR-T...
[1]Nagarsheth NB,et al.TCR-engineered T cells targeting E7 for patients with linkstatic HPV-associated epithelial cancers. Nat Med. 2021 Mar;27(3):419-425.https://pmc.ncbi.nlm.nih.gov/articles/PMC9620481/ [2]Xia Y,et al.Treatment of linkstatic nonsmall cell lung cancer with NYESO1 ...
[3]Xia Y,et al.Treatment of linkstatic nonsmall cell lung cancer with NYESO1 specific TCR engineeredT cells in a phase I clinical trial: A case report[J]. oncology letters, 2018, 16(6): 6998-7007.https://www.spandidos publications.com/10.3892/ol.2018.9534?text=abstract [4]Simnica ...
[3]Xia Y,et al.Treatment of linkstatic nonsmall cell lung cancer with NYESO1 specific TCR engineeredT cells in a phase I clinical trial: A case report[J]. oncology letters, 2018, 16(6): 6998-7007. https://www.spandidos-publications.com/10.3892/ol.2018.9534 ...